ShareValue scores for ACT.JSE: Valuation 69, Quality 46, Growth 23, Health 49.

ACT.JSE
JSE

AfroCentric Investment Corp

ZAR 0.77(0.00%)
Loading chart...
Sentiment

Verdicts

Rating

Trap Risk

Return

6% to 16%
Valuation
69
Fair Value
Price vs Value
Quality
46
Moderate
Business Strength
Growth
23
Weak
Revenue & Earnings
Health
49
Moderate
Financial Stability
Momentum
48
Neutral
Price Trend

Company Details

About

AfroCentric Investment Corporation Limited, an investment holding company, provides healthcare products and services to private and public sectors in South Africa and internationally. The company operates through Healthcare SA, Healthcare Retail, Healthcare Africa, and Information Technology segments. It offers health administration, health risk management, medical scheme administration, marketing and distribution, as well as specialized and technology-based products and services; HIV/AIDS management; DBC equipment and administration services to musculoskeletal treatment centres; and dental management services. The company also engages in the manufacture, distribution, marketing, and retail of medicines and pharmaceutical products under the Pharmacy Direct, Curasana, Activo Health, and Scriptpharm brand names. In addition, it provides health insurance products for individuals and organisations; occupational health programmes; administration services for a market of medical schemes, health insurers and corporate clients; wellness programmes, including health risk assessments, corporate nursing, lifestyle initiatives, executive wellness, and employee assistance programmes; chronic condition monitoring, referrals, health education and emergency services; and gap cover, a short-term insurance product that offers additional financial protection to medical aid members. The company was incorporated in 1988 and is based in Roodepoort, South Africa. AfroCentric Investment Corporation Limited is a subsidiary of Sanlam Life Insurance Limited. Address: 37 Conrad Road, Roodepoort, South Africa, 1709

Score Analysis

AI Investment Thesis

Data as of:Aug 7, 2026
|
Last calculated:Aug 7, 2026